Hirotake Suzuki, Binghe Wang, Gulnar M

Slides:



Advertisements
Similar presentations
Therapeutic Potential of B and T Lymphocyte Attenuator Expressed on CD8+ T Cells for Contact Hypersensitivity  Daiki Nakagomi, Kotaro Suzuki, Junichi.
Advertisements

Tatsukuni Ohno, Yuta Kondo, Chenyang Zhang, Siwen Kang, Miyuki Azuma 
Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1  Katelynn A. Milora, Hangfei Fu, Ornella Dubaz,
Photobiologic and Photoimmunologic Characteristics of XPA Gene-Deficient Mice  Takeshi Horio, Hiroko Miyauchi-Hashimoto, Kazue Kuwamoto, Satoshi Horiki,
Upregulation of Inflammatory Cytokines and Oncogenic Signal Pathways Preceding Tumor Formation in a Murine Model of T-Cell Lymphoma in Skin  Xuesong Wu,
Corticosteroids But Not Pimecrolimus Affect Viability, Maturation and Immune Function of Murine Epidermal Langerhans Cells  Wolfram Hoetzenecker, Josef.
Topical ROR Inverse Agonists Suppress Inflammation in Mouse Models of Atopic Dermatitis and Acute Irritant Dermatitis  Jun Dai, Min-Kyung Choo, Jin Mo.
PD-1 on Immature and PD-1 Ligands on Migratory Human Langerhans Cells Regulate Antigen-Presenting Cell Activity  Victor Peña-Cruz, Sean M. McDonough,
Oxidation of Cell Surface Thiol Groups by Contact Sensitizers Triggers the Maturation of Dendritic Cells  Saori Kagatani, Yoshinori Sasaki, Morihiko Hirota,
UVB Radiation-Mediated Inhibition of Contact Hypersensitivity Reactions Is Dependent on the Platelet-Activating Factor System  Qiwei Zhang, Yongxue Yao,
Human Keratinocytes Express Functional CD14 and Toll-Like Receptor 4
Liver X Receptor Activators Display Anti-Inflammatory Activity in Irritant and Allergic Contact Dermatitis Models: Liver-X-Receptor-Specific Inhibition.
Absence of CCR4 Exacerbates Skin Inflammation in an Oxazolone-Induced Contact Hypersensitivity Model  Sari Lehtimäki, Sari Tillander, Anne Puustinen,
IL-27 Activates Th1-Mediated Responses in Imiquimod-Induced Psoriasis-Like Skin Lesions  Sayaka Shibata, Yayoi Tada, Yoshihide Asano, Koichi Yanaba, Makoto.
Cellular Fibronectin is Induced in Ultraviolet-Exposed Human Skin and Induces IL-10 Production by Monocytes/Macrophages  Yuichi Yoshida, Kefei Kang, Guofen.
Topical Peroxisome Proliferator Activated Receptor-α Activators Reduce Inflammation in Irritant and Allergic Contact Dermatitis Models1  Mary Y. Sheu,
IL-23 from Langerhans Cells Is Required for the Development of Imiquimod-Induced Psoriasis-Like Dermatitis by Induction of IL-17A-Producing γδ T Cells 
Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis  Erin G. Harper, Changsheng Guo,
Langerhans Cells Are Required for UVR-Induced Immunosuppression
Animal Model of Sclerotic Skin
Volume 23, Issue 6, Pages (December 2005)
IL-10-Producing Langerhans Cells and Regulatory T Cells Are Responsible for Depressed Contact Hypersensitivity in Grafted Skin  Ryutaro Yoshiki, Kenji.
Capsiate Inhibits DNFB-Induced Atopic Dermatitis in NC/Nga Mice through Mast Cell and CD4+ T-Cell Inactivation  Ji H. Lee, Yun S. Lee, Eun-Jung Lee, Ji.
Toll-Like Receptor 3 Increases Allergic and Irritant Contact Dermatitis  Naomi Nakamura, Risa Tamagawa-Mineoka, Mayumi Ueta, Shigeru Kinoshita, Norito.
Urupongsa Ausaneya, Akira Kawada, Yoshinori Aragane 
IL-18, but Not IL-12, Induces Production of IFN-γ in the Immunosuppressive Environment of HPV16 E7 Transgenic Hyperplastic Skin  Christina Gosmann, Ian.
Interleukin-1β But Not Tumor Necrosis Factor is Involved in West Nile Virus-Induced Langerhans Cell Migration from the Skin in C57BL/6 Mice  Scott N.
Integrin αE(CD103) Is Involved in Regulatory T-Cell Function in Allergic Contact Hypersensitivity  Andrea Braun, Nadin Dewert, Fiona Brunnert, Viktor.
Antisense Targeting of cFLIP Sensitizes Activated T Cells to Undergo Apoptosis and Desensitizes Responses to Contact Dermatitis  Dan V. Mourich, Jessica.
Silvina Gazzaniga, Alicia Bravo, Silvana R
Exacerbated and Prolonged Allergic and Non-Allergic Inflammatory Cutaneous Reaction in Mice with Targeted Interleukin-18 Expression in the Skin  Yusuke.
Sri Rajalakshmi Rudrabhatla, Christie L. Mahaffey, Mark E. Mummert 
BAFF Antagonist Attenuates the Development of Skin Fibrosis in Tight-Skin Mice  Takashi Matsushita, Manabu Fujimoto, Minoru Hasegawa, Yukiyo Matsushita,
Anne T. Funding, Claus Johansen, Matthias Gaestel, Bo M
Topical Imiquimod Treatment Prevents UV-Light Induced Loss of Contact Hypersensitivity and Immune Tolerance  Thomas H. Thatcher, Irina Luzina, Rita Fishelevich,
CD24a Expression Levels Discriminate Langerhans Cells from Dermal Dendritic Cells in Murine Skin and Lymph Nodes  Susanne Stutte, Bettina Jux, Charlotte.
Prominent Production of IL-20 by CD68+/CD11c+ Myeloid-Derived Cells in Psoriasis: Gene Regulation and Cellular Effects  Frank Wang, Edmund Lee, Michelle.
The Differential Role of L-Selectin and ICAM-1 in Th1-Type and Th2-Type Contact Hypersensitivity  Asako Ogawa, Ayumi Yoshizaki, Koichi Yanaba, Fumihide.
SPLA2-X Stimulates Cutaneous Melanocyte Dendricity and Pigmentation Through a Lysophosphatidylcholine-Dependent Mechanism  Glynis A. Scott, Stacey E.
Lymphatic Dysfunction Impairs Antigen-Specific Immunization, but Augments Tissue Swelling Following Contact with Allergens  Makoto Sugaya, Yoshihiro Kuwano,
Impaired Initiation of Contact Hypersensitivity by FTY720
Epicutaneous Natural Rubber Latex Sensitization Induces T Helper 2-Type Dermatitis and Strong Prohevein-Specific IgE Response  Maili Lehto, Minna Koivuluhta,
Epithelial Cells in the Hair Follicle Bulge do not Contribute to Epidermal Regeneration after Glucocorticoid-Induced Cutaneous Atrophy  Dmitry V. Chebotaev,
SOCS3 Expressed in M2 Macrophages Attenuates Contact Hypersensitivity by Suppressing MMP-12 Production  Kazuyuki Meguro, Daiki Nakagomi, Kotaro Suzuki,
Liver X Receptor Activators Display Anti-Inflammatory Activity in Irritant and Allergic Contact Dermatitis Models: Liver-X-Receptor-Specific Inhibition.
Β-Arrestin 2 Inhibits Proinflammatory Chemokine Production and Attenuates Contact Allergic Inflammation in the Skin  Evelyn Gaffal, Mira Jakobs, Nicole.
Ulrich Zügel, Khusru Asadullah  Journal of Investigative Dermatology 
Wound Healing in the α2β1 Integrin-Deficient Mouse: Altered Keratinocyte Biology and Dysregulated Matrix Metalloproteinase Expression  David G. Grenache,
Afferent and Efferent Phases of Allergic Contact Dermatitis (ACD) Can Be Induced After a Single Skin Contact with Haptens: Evidence Using a Mouse Model.
Murine Epidermal Label-Retaining Cells Isolated by Flow Cytometry do not Express the Stem Cell Markers CD34, Sca-1, or Flk-1  Michael R. Albert, Ruth-Ann.
Overexpression of IL-4 Alters the Homeostasis in the Skin
Timothy J. Paradis, Susan H. Cole, Robin T. Nelson, Ronald P. Gladue 
Engagement of CD47 Inhibits the Contact Hypersensitivity Response Via the Suppression of Motility and B7 Expression by Langerhans Cells  Xijun Yu, Atsushi.
TGFβ1 Overexpression by Keratinocytes Alters Skin Dendritic Cell Homeostasis and Enhances Contact Hypersensitivity  Javed Mohammed, Andrew J. Gunderson,
Agatha Schwarz, Anika Bruhs, Thomas Schwarz 
Linda J. Johnston, Nicholas J.C. King 
Jun Asai, Hideya Takenaka, Norito Katoh, Saburo Kishimoto 
Smad3 Signal Transducer Regulates Skin Inflammation and Specific IgE Response in Murine Model of Atopic Dermatitis  Minna Anthoni, Guoying Wang, Chuxia.
Repeated Topical Challenge with Chemical Antigen Elicits Sustained Dermatitis in NC/Nga Mice in Specific-Pathogen-Free Condition  Yoshiaki Tomimori, Yoshitaka.
Javed Mohammed, Andrew Ryscavage, Rolando Perez-Lorenzo, Andrew J
Cutaneous Hypersensitivities to Hapten Are Controlled by IFN-γ-Upregulated Keratinocyte Th1 Chemokines and IFN-γ-Downregulated Langerhans Cell Th2 Chemokines 
Formation of Antigenic Quinolone Photoadducts on Langerhans Cells Initiates Photoallergy to Systemically Administered Quinolone in Mice  Akihiro Ohshima,
Solar-Simulated Ultraviolet Radiation-Induced Upregulation of the Melanocortin-1 Receptor, Proopiomelanocortin, and α-Melanocyte-Stimulating Hormone in.
Regulation of Tissue Factor in Microvascular Dermal Endothelial Cells
CpG Immunostimulatory Sequences Enhance Contact Hypersensitivity Responses in Mice  Hitoshi Akiba, Masataka Satoh, Keiji Iwatsuki, Dominique Kaiserlian,
Skin-Infiltrating Monocytes/Macrophages Migrate to Draining Lymph Nodes and Produce IL-10 After Contact Sensitizer Exposure to UV-Irradiated Skin  Eiko.
Modulation of IL-10, IL-12, and IFN-γ in the Epidermis of Hairless Mice by UVA (320– 400 nm) and UVB (280–320 nm) Radiation  Jie Shen, Shisan Bao, Vivienne.
Patrizia Stoitzner, Christoph H
Adenosine Slows Migration of Dendritic Cells but Does Not Affect Other Aspects of Dendritic Cell Maturation  Susanne Hofer, Lennart Ivarsson, Patrizia.
UV Exposure Boosts Transcutaneous Immunization and Improves Tumor Immunity: Cytotoxic T-Cell Priming through the Skin  Pamela Stein, Gerd Rechtsteiner,
Presentation transcript:

Imiquimod, a Topical Immune Response Modifier, Induces Migration of Langerhans Cells1  Hirotake Suzuki, Binghe Wang, Gulnar M. Shivji, Paola Toto, Paolo Amerio, Daniel N. Sauder  Journal of Investigative Dermatology  Volume 114, Issue 1, Pages 135-141 (January 2000) DOI: 10.1046/j.1523-1747.2000.00833.x Copyright © 2000 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 Effect of imiquimod on Langerhans cell density with immunolabeling. Topical imiquimod or vehicle was applied to the skin of mice and skin was obtained from 0 to 10 d post-treatment. Epidermis was separated from dermis and stained for Ia+ cells as described in Materials and Methods. A decrease in Langerhans cell density was noted 2 d after treatment (p < 0.05) falling to approximately 43% of control by day 10 (184 ± 16 vs 432 ± 21 cells per mm2, p < 0.05). Journal of Investigative Dermatology 2000 114, 135-141DOI: (10.1046/j.1523-1747.2000.00833.x) Copyright © 2000 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 2 Effect of imiquimod on Langerhans cell morphology. Topical imiquimod or vehicle was applied to the skin of mice, then skin was obtained from 0 to 10 d post-treatment. Epidermis was separated from dermis and stained for Ia+ cells as described in the Materials and Methods. A representative photomicrograph from day 10 is shown. Langerhans cells in the imiquimod-treated group appeared larger with brighter Ia antigen staining (a) compared with control (b); magnification × 400. These changes were seen from day 2 to day 10. Scale bar: 50 μm. Journal of Investigative Dermatology 2000 114, 135-141DOI: (10.1046/j.1523-1747.2000.00833.x) Copyright © 2000 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 3 Imiquimod decreased the number of Langerhans cells in epidermis but did not activate expression of B7. Mice were treated with imiquimod or vehicle alone for 7 d then single cell suspension was prepared. Cells were immunolabeled with anti-Ia and anti-B7 (B7-1/CD80 or B7-2/CD86) using a two-color immunofluorescence of FITC and PE. A decreased number of Langerhans cells was observed in the 7 d imiquimod-treated group (a) compared with the placebo-treated group (b). Flow cytometric gate was chosen so that the isotype control had ≤ 0.1% positive cells 9c). No change was seen in B7-1 and B7-2 expression with imiquimod treatment. Journal of Investigative Dermatology 2000 114, 135-141DOI: (10.1046/j.1523-1747.2000.00833.x) Copyright © 2000 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 4 Imiquimod reduces Langerhans cell density. (a, b) Effect of imiquimod on Langerhans cell density by ATPase staining. Imiquimod or vehicle alone was applied to dorsum of each ear once a day for 7 d. Epidermis was separated from dermis and stained for ATPase+ cells (Langerhans cells) as described in the Materials and Methods. A significant decrease in the density of Langerhans cells was observed in the imiquimod-treated group (a) compared with control (b); magnification × 400. Scale bar: 50 μm. (c) Langerhans cells were enumerated by examining at least 10 random fields in each group. Langerhans cell density decreased by approximately 61% compared with control (150 ± 7 vs 247 ± 10 cells per mm2, p < 0.05). Journal of Investigative Dermatology 2000 114, 135-141DOI: (10.1046/j.1523-1747.2000.00833.x) Copyright © 2000 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 5 Effect of imiquimod on Langerhans cell migration. Mice were treated with topical imiquimod or vehicle alone, then FITC was applied epicutaneously. Twenty-four hours later DLN were obtained and single cell suspensions were prepared, immunolabeled with anti-Ia/PE and then analyzed for PE/FITC-labeled cells as described in Materials and Methods. Enhanced Langerhans cell migration was seen in the imiquimod-treated group (b) compared with the vehicle-treated control group (a). Flow cytometric gate was chosen so that the negative control (no FITC) had ≤ 0.1% positive cells (c). Journal of Investigative Dermatology 2000 114, 135-141DOI: (10.1046/j.1523-1747.2000.00833.x) Copyright © 2000 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 6 Imiquimod enhances allergic contact hypersensitivity. (A) Mice were treated with topical imiquimod or vehicle alone (control 1), and then CHS was induced by DNFB. For further control CHS was induced on the mice without chemical treatment (control 2). Mice were challenged on the dorsal surface of ears and ear thickness was measured as a manifestation of CHS (mean ± SEM). (B) Imiquimod did not alter irritant contact hypersensitivity. Mice were treated with topical imiquimod or vehicle alone (control 1), and then irritation was induced by croton oil. As a further negative control, irritation was induced with croton oil in mice receiving no pretreatment (control 2). Ear thickness was measured as a manifestation of irritation after 24 h (mean ± SEM). Journal of Investigative Dermatology 2000 114, 135-141DOI: (10.1046/j.1523-1747.2000.00833.x) Copyright © 2000 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 7 Imiquimod upregulates cytokines mRNA expression. (A) Twenty-four hours after challenge, total RNA from the challenge skin site was obtained, and mRNA expression for IL-6, 10, IFN-α, IFN-γ, TNF-α, and β-actin was evaluated by reverse transcriptase–PCR. PCR products were resolved an agarose gel and photographed under ultraviolet light. Imiquimod-treated group (I) and vehicle-treated group (C). (B) The densitometry values for each cytokine were quantitated by determining the ratio of the cytokine mRNA to that of β-actin. Imiquimod-treated group (I) demonstrated enhanced cytokine expression compared with the vehicle-treated group (C). Journal of Investigative Dermatology 2000 114, 135-141DOI: (10.1046/j.1523-1747.2000.00833.x) Copyright © 2000 The Society for Investigative Dermatology, Inc Terms and Conditions